Last reviewed · How we verify
NCT04771741
Opiate Free Multimodal Pain Pathway in Elective Foot and Ankle Surgery: A Prospective Study
trial testing Acetominophen in Bunion of Unspecified Foot in 72 participants. Completed in 26 April 2023.
31 December 2022
Quick facts
| Lead sponsor | Prisma Health-Midlands |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 72 |
| Start date | 1 December 2020 |
| Primary completion | 31 December 2022 |
| Estimated completion | 26 April 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Acetominophen — full drug profile →
- Toradol (KETOROLAC) — full drug profile →
- Meloxicam (MELOXICAM) — full drug profile →
- Cyclobenzaprine (CYCLOBENZAPRINE) — full drug profile →
- Lyrica (Pregabalin) — full drug profile →
Conditions studied
- Bunion of Unspecified Foot — all drugs for Bunion of Unspecified Foot →
- Bunionette of Unspecified Foot — all drugs for Bunionette of Unspecified Foot →
- Hammertoe — all drugs for Hammertoe →
- Ankle Fractures — all drugs for Ankle Fractures →
Sponsor
Prisma Health-Midlands — full company profile →
Who can join
Adults 18 to 99, any sex, with Bunion of Unspecified Foot or Bunionette of Unspecified Foot. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Orthopedic surgeons frequently prescribe and over-prescribe narcotic pain medications during the postoperative period, despite the ongoing opioid crisis in the United States. While opioid-free multimodal pathways have shown promising results, there remains a lack of published literature evaluating opiate-free multimodal pain protocols for elective outpatient foot and ankle surgeries. This study aims to evaluate post-operative pain following the use of an opioid-free pain treatment plan for patients undergoing foot and ankle surgeries.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04771741
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Acetominophen
Trials testing the same drug.
- NCT04378114 — Impact of Acetaminophen on Performance of Guardian™ Sensor (3) in Adults · NA · completed
Other Prisma Health-Midlands trials
Trials by the same sponsor.
- NCT05678231 — Zero Degree Knee Positioner for Improved Earley Knee Extension Following Total Knee Arthroplasty · NA · active not recruiting
- NCT05281562 — Immunonutrition for Diabetic Foot Ulcers · Phase 2, PHASE3 · terminated
- NCT05707013 — HP Arize 3D Orthotics for Planar Fasciitis · NA · active not recruiting
- NCT05138549 — Astaxanthin for Management of Inflammation in Knee Osteoarthritis · Phase 2, PHASE3 · terminated
- NCT03743805 — Rapid Reversal of CNS-Depressant Drug Effect Prior to Brain Death Determination · EARLY_PHASE1 · withdrawn
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04771741 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Prisma Health-Midlands
- Last refreshed: 27 April 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04771741.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing